Nicolas Palaskas, MD

Peer-Reviewed Articles

1. Abe JI, Imanishi M, Li S, Zhang A, Ko KA, Samanthapudi VSK, Lee LL, Bojorges AP, Gi YJ, Hobbs BP, Deswal A, Herrmann J, Lin SH, Chini EN, Shen YH, Schadler KL, Nguyen TH, Gupte AA, Reyes-Gibby C, Yeung SJ, Abe RJ, Olmsted-Davis EA, Krishnan S, Dantzer R, Palaskas NL, Cooke JP, Pownall HJ, Yoshimoto M, Fujiwara K, Hamilton DJ, Burks JK, Wang G, Le NT, Kotla S. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circ Res 133(1):25-44, 2023. e-Pub 2023. PMID: 37264926.
2. Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, Stein F, Bretagne M, Ederhy S, Fenioux C, Hamwy O, Funck-Brentano E, Romano E, Pieroni L, Münster J, Allenbach Y, Anquetil C, Leonard-Louis S, Palaskas NL, Hayek SS, Katus HA, Giannitsis E, Frey N, Kaya Z, Moslehi J, Prifti E, Salem JE, International ICI-Myocarditis Registry Contributors. Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation. e-Pub 2023. PMID: 37317858.
3. Ewer MS, Palaskas NL, Herson J. Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anti-Cancer treatments: Do the Data Support the Recommendations?. J Pharmacol Exp Ther. e-Pub 2023. PMID: 37105580.
4. Nguyen MTH, Imanishi M, Li S, Chau K, Banerjee P, Velatooru LR, Ko KA, Samanthapudi VSK, Gi YJ, Lee LL, Abe RJ, McBeath E, Deswal A, Lin SH, Palaskas NL, Dantzer R, Fujiwara K, Borchrdt MK, Turcios EB, Olmsted-Davis EA, Kotla S, Cooke JP, Wang G, Abe JI, Le NT. Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition. Front Cardiovasc Med 10:1187490, 2023. e-Pub 2023. PMID: 37711550.
5. Jain A, Casanova D, Padilla AV, Paniagua Bojorges A, Kotla S, Ko KA, Samanthapudi VSK, Chau K, Nguyen MTH, Wen J, Hernandez Gonzalez SL, Rodgers SP, Olmsted-Davis EA, Hamilton DJ, Reyes-Gibby C, Yeung SJ, Cooke JP, Herrmann J, Chini EN, Xu X, Yusuf SW, Yoshimoto M, Lorenzi PL, Hobbs B, Krishnan S, Koutroumpakis E, Palaskas NL, Wang G, Deswal A, Lin SH, Abe JI, Le NT. Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. Front Cardiovasc Med 10:1212174, 2023. e-Pub 2023. PMID: 37781317.
6. Kim JW, Monlezun D, Park JK, Chauhan S, Balanescu D, Koutroumpakis E, Palaskas N, Kim P, Hassan S, Botz G, Crommett J, Reddy D, Cilingiroglu M, Marmagkiolis K, Iliescu C. Post-cardiac arrest PCI is underutilized among cancer patients: Machine learning augmented nationally representative case-control study of 30 million hospitalizations. Resuscitation 179:43-49, 2022. e-Pub 2022. PMID: 35933056.
7. Ulndreaj A, Brinc D, Altan M, Pons-Belda OD, Fernandez-Uriarte A, Mu-Mosley H, Fattah F, von Itzstein MS, Soosaipillai A, Kulasingam V, Palaskas NL, Gerber DE, Diamandis EP, Heymach JV, Prassas I. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study. Clin Chem Lab Med. e-Pub 2022. PMID: 36287134.
8. Potter AS, Patel A, Khawaja M, Chen C, Zheng H, Kaczmarek J, Gao F, Karimzad K, Song J, Koutroumpakis E, Khalaf S, Iliescu C, Deswal A, Palaskas NL. Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer. JACC CardioOncol 4(3):341-350, 2022. e-Pub 2022. PMID: 36213361.
9. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE, International ICI-myocarditis registry contributors. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer. e-Pub 2022. PMID: 36030143.
10. Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma. Haematologica 107(7):1555-1566, 2022. e-Pub 2022. PMID: 34758610.
11. Koutroumpakis E, Deswal A, Yusuf SW, Abe JI, Nead KT, Potter AS, Liao Z, Lin SH, Palaskas NL. Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep 24(5):543-553, 2022. e-Pub 2022. PMID: 35192118.
12. Shobayo F, Bajwa M, Koutroumpakis E, Hassan SA, Palaskas NL, Iliescu C, Abe JI, Mouhayar E, Karimzad K, Thompson KA, Deswal A, Yusuf S. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. e-Pub 2022. PMID: 35412407.
13. Wang X, Palaskas NL, Hobbs BP, Abe JI, Nead KT, Yusuf SW, Hermann J, Deswal A, Lin SH. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267613.
14. Ahmed T, Mouhayar E, Song J, Koutroumpakis E, Palaskas NL, Yusuf SW, Lopez-Mattei J, Hassan SA, Kim P, Cilingiroglu M, Marmagkiolis K, Vaporciyan AA, Swisher S, Deswal A, Iliescu C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med 9:916325, 2022. e-Pub 2022. PMID: 35711368.
15. Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging 2, 2022. e-Pub 2022. PMID: 35801078.
16. Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, Liao Z, Nurieva R, Amir ED, Burks JK, Palaskas NL, Cooke JP, Lin SH, Kobayashi M, Yoshimoto M, Abe JI. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med 9:988713, 2022. e-Pub 2022. PMID: 36426217.
17. Safdar A, Ahmed T, Liu VY, Addoumieh A, Agha AM, Giza DE, Balanescu DV, Donisan T, Dayah T, Lopez-Mattei JC, Kim PY, Hassan S, Karimzad K, Palaskas N, Tsai JY, Iliescu GD, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu CA. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med 9:1019284, 2022. e-Pub 2022. PMID: 36386379.
18. Lipe DN, Rajha E, Wechsler AH, Gaeta S, Palaskas NL, Alhajji Z, Viets-Upchurch J, Chaftari P. Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy. Am J Emerg Med 50:51-58, 2021. e-Pub 2021. PMID: 34274878.
19. Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol 6(11):1329-1337, 2021. e-Pub 2021. PMID: 34232253.
20. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehman L, Ederhy S, Moslehi J, Salem JE, International ICI-Myocarditis Registry†. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation 144(18):1521-1523, 2021. e-Pub 2021. PMID: 34723640.
21. Palaskas NL, Segura A, Lelenwa L, Siddiqui BA, Subudhi SK, Lopez-Mattei J, Durand JB, Deswal A, Zhao B, Maximilian Buja L, Iliescu C. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail 23(10):1725-1735, 2021. e-Pub 2021. PMID: 34114291.
22. Javaid AI, Monlezu DJ, Iliescu G, Tran P, Eilipescu A, Palaskas N, Lopez-Mattei J, Hassan S, Madjid M, Cilingiroglu M, Charitakis K, Marmagkiolis K, Iliescu c, Koutroumpakis E. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type. ESC Heart Failure, 2021.
23. Fadol AP, Patel A, Shelton V, Krause KJ, Bruera E, Palaskas NL. Palliative care referral criteria and outcomes in cancer and heart failure: a systematic review of literature. Cardiooncology 7(1):32, 2021. e-Pub 2021. PMID: 34556191.
24. Balanescu DV, Aziz MK, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Song J, Ntim W, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis 32(4):295-301, 2021. e-Pub 2020. PMID: 33196581.
25. Monlezun DJ, Hostetter L, Balan P, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Iakobishvili Z, Ewer M, Marmagkiolis K, Iliescu C. TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients. Cardiooncology 7(1):25, 2021. e-Pub 2021. PMID: 34183072.
26. Aldrich J, Pundole X, Tummala S, Palaskas N, Andersen CR, Shoukier M, Abdel-Wahab N, Deswal A, Suarez-Almazor ME. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol 73(5):866-874, 2021. e-Pub 2021. PMID: 33258544.
27. Kherallah RY, Harrison D, Preventza O, Silva GV, Dougherty KG, Coulter SA, Simpson L, Strickman NE, Mortazavi A, Palaskas N, Fish RD, Krajcer Z, Stainback RF, Gomez JCP, Livesay JJ, Coselli JS, Koneru S. Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329:50-55, 2021. e-Pub 2020. PMID: 33359282.
28. Gill C, Lee M, Balanescu DV, Donisan T, Serauto Canache AJ, Palaskas N, Lopez-Mattei J, Kim PY, Song J, Yang EH, Cilingiroglu M, Kar B, Gregoric I, Marmagkiolis K, Iakobishvili Z, Iliescu C. Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule. Int J Cardiol 326:62-70, 2021. e-Pub 2020. PMID: 32858137.
29. Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, Palaskas N, Durand JB, Leung CH, Lopez-Mattei J. QT Prolongation in Cancer Patients. Front Cardiovasc Med 8:45, 2021. e-Pub 2021. PMID: 33718445.
30. Bravo-Jaimes K, Palaskas NL, Banchs J, Abelhad NI, Altaf A, Gouni S, Song J, Hassan SA, Iliescu C, Deswal A, Yusuf SW. Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med 8:644264, 2021. e-Pub 2021. PMID: 33816575.
31. Abe RJ, Savage H, Imanishi M, Banerjee P, Kotla S, Paez-Mayorga J, Taunton J, Fujiwara K, Won JH, Yusuf SW, Palaskas NL, Banchs J, Lin SH, Schadler KL, Abe JI, Le NT. Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway. Front Cardiovasc Med 8:663486, 2021. e-Pub 2021. PMID: 33681312.
32. Koutroumpakis E, Hashmi SS, Powell C, Fatakdawala M, Pang J, Patel R, Thannoun T, Grable C, Damaraju S, Badruddin Mawji S, Lin K, Folivi M, Chauhan S, Shabbir MA, Hughes K, Peters TK, Lyubarova R, Damaraju S, Palaskas N, Deswal A, Garcia-Sayan E, Taegtmeyer H. Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA. Cardiology 146(4):481-488, 2021. e-Pub 2021. PMID: 33902039.
33. Wilson NR, Lee MT, Gill CD, Serauto Canache A, Donisan T, Balanescu DV, Song J, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Marmagkiolis K, Iliescu CA. Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia. Front Cardiovasc Med 8:638943, 2021. e-Pub 2021. PMID: 33969007.
34. Agha AM, Palaskas N, Patel AR, DeCara J, Parwani P, Iliescu C, Durand JB, Kim P, Hassan S, Gladish G, Lee HC, Kaufman GP, Lopez-Mattei JC. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med 8:626414, 2021. e-Pub 2021. PMID: 34268341.
35. Abdulla A, Durand JB, Lopez-Mattei J, Palaskas N. A Rare Case of Testicular Teratoma Metastasizing to the Right Ventricle. JACC Case Rep 3(1):117-119, 2021. e-Pub 2021. PMID: 34317482.
36. Heidari-Bateni G, Durand JB, Iliescu C, Gladish G, Deswal A, Patel AR, Kim P, Song J, Hassan S, Palaskas N, Baldassarre LA, Bucciarelli-Ducci C, Lopez-Mattei J. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med 8:734820, 2021. e-Pub 2021. PMID: 34765654.
37. Jacob R, Strati P, Palaskas N, Lopez-Mattei JC, Marmagkiolis K, Buja LM, Deswal A, Iliescu C. Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy. JACC Case Rep 2(13):2095-2100, 2020. e-Pub 2020. PMID: 34317115.
38. Palaskas NL, Deswal A. In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization. Ann Intern Med 173(10):JC51, 2020. PMID: 33197352.
39. Balanescu DV, Donisan T, Deswal A, Palaskas N, Song J, Lopez-Mattei J, Kim PY, Durand JB, Doundoua D, Marmagkiolis K, Iliescu C. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol 313:1-8, 2020. e-Pub 2020. PMID: 32320781.
40. Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Kim PY, Buja LM, McNamara DM, Kobashigawa JA, Durand JB, Iliescu CA. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy. Cardiovasc Pathol 47:107211, 2020. e-Pub 2020. PMID: 32268262.
41. Palaskas N, Lopez-Mattei J. Cancer therapy cardiotoxicity detection: understanding the limitations of cardiac imaging. Heart 106(11):791-792, 2020. e-Pub 2020. PMID: 32179588.
42. Wang X, Palaskas NL, Yusuf SW, Abe JI, Lopez-Mattei J, Banchs J, Gladish GW, Lee P, Liao Z, Deswal A, Lin SH. Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol. e-Pub 2020. PMID: 32599073.
43. Mohamed MO, Lopez-Mattei JC, Parwani P, Iliescu CA, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts J, Kwok CS, Gulati M, Al Zubaidi AMB, Mamas MA. Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations. Int J Clin Pract 74(5):e13476, 2020. e-Pub 2020. PMID: 31922635.
44. Lopez-Mattei J, Verstovsek S, Fellman B, Iliescu C, Bhatti K, Hassan SA, Kim P, Gray BA, Palaskas NL, Grosu HB, Mamas MA, Faiz SA. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol 99(4):781-789, 2020. e-Pub 2020. PMID: 32076825.
45. Quintana RA, Bui LP, Moudgil R, Palaskas N, Hassan S, Abe JI, Mouhayar E, Yusuf SW, Hernandez A, Banchs J. Speckle-Tracking Echocardiography in Cardio-Oncology and Beyond. Tex Heart Inst J 47(2):96-107, 2020. PMID: 32603473.
46. Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Iliescu C. Halloween in the Cath Lab: spider web pericardial effusion. Eur Heart J Cardiovasc Imaging 21(3):317, 2020. e-Pub 2019. PMID: 31501856.
47. Agha AM, Gill C, Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim PY, Charitakis K, Cilingiroglu M, Oo TH, Kroll M, Durand JB, Hirsch-Ginsberg C, Marmagkiolis K, Iliescu C. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med 7:9, 2020. e-Pub 2020. PMID: 32118047.
48. Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc 9(2):e013757, 2020. e-Pub 2020. PMID: 31960755.
49. Fadol AP, Palaskas NL, Ewer MS, Deswal A. An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020. Cardiooncology 6:20, 2020. e-Pub 2020. PMID: 32944289.
50. Abe RJ, Savage H, Imanishi M, Banerjee P, Kotla S, Paez-Mayorga J, Taunton J, Fujiwara K, Won JH, Yusuf SW, Palaskas NL, Banchs J, Lin SH, Schadler KL, Abe JI, Le NT. p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway. Front Cardiovasc Med 7:542485, 2020. e-Pub 2020. PMID: 33304925.
51. Nguyen HL, Goebel M, Palaskas N, McCants D. Tropheryma whipplei- A rare and diagnostically challenging cause of culture-negative endocarditis. Int J Case Rep Images 11, 2020.
52. Borovac JA, Kwok CS, Iliescu C, Lee HJ, Kim PY, Palaskas NL, Zaman A, Butler R, Lopez-Mattei JC, Mamas MA. Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). Am J Cardiol 124(8):1190-1197, 2019. e-Pub 2019. PMID: 31395298.
53. Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2018. PMID: 30543051.
54. Kitkungvan D, Kalluru D, Lunagariya A, Sanchez L, Yusuf SW, Hassan S, Palaskas N, Mouhayar E, Banchs J. Safety of Transesophageal Echocardiography in Patients with Thrombocytopenia. J Am Soc Echocardiogr 32(8):1010-1015, 2019. e-Pub 2019. PMID: 31239084.
55. Balanescu DV, Donisan T, Dayah T, Palaskas N, Lopez-Mattei J, Kim P, Pinnix CC, Moudgil R, Balanescu SM, Herrmann J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging 35(5):759-760, 2019. e-Pub 2019. PMID: 30758691.
56. Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
57. Balanescu DV, Monlezun DJ, Donisan T, Boone D, Cervoni-Curet F, Palaskas N, Lopez-Mattei J, Kim P, Iliescu C, Balanescu SM. A Cancer Paradox: Machine-Learning Backed Propensity-Score Analysis of Coronary Angiography Findings in Cardio-Oncology. J Invasive Cardiol 31(1):21-26, 2019. PMID: 30611123.
58. Iliescu C, Balanescu DV, Donisan T, Giza DE, Muñoz Gonzalez ED, Cilingiroglu M, Song J, Mukerji SS, Lopez-Mattei JC, Kim PY, Palaskas N, Mouhayar EN, Durand JB, Marmagkiolis K. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients with Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol 122(9):1465-1470, 2018. e-Pub 2018. PMID: 30180958.
59. Kitkungvan D, Yusuf SW, Moudgil R, Palaskas N, Guindani M, Juhee S, Hassan S, Sanchez L, Banchs J. Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction. Echocardiography 35(10):1512-1518, 2018. e-Pub 2018. PMID: 30005128.
60. Potter A, Patel A, Khawaja M, Chen C, Zheng H, Kaczmarek J, Gao F, Karimzad K, Song J, Koutroumpakis E, Khalaf S, Iliescu C, Deswal A, Palaskas NL.. Outcomes of stroke and bleeding by class of anticoagulant use for non-valvular atrial fibrillation in patients with active cancer. JACC:CardioOncology.

Invited Articles

1. Lipe DN, Chaftari P, Reyes-Gibby C, Palaskas NL. The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicity. Am J Emerg Med 57:220-221, 2022. e-Pub 2022. PMID: 35246349.
2. Manohar H, Potter AS, Koutroumpakis E, Deswal A, Palaskas NL. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?. Curr Atheroscler Rep. e-Pub 2022. PMID: 35624391.
3. Lipe DN, Palaskas NL, Chaftari P. Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis. J Med Toxicol 18(1):63-64, 2022. e-Pub 2021. PMID: 34227031.
4. Jacob R, Palaskas NL, Lopez-Mattei J, Hassan S, Kim P, Donisan T, Balanescu DV, Cilingiroglu M, Marmagkiolis K, Iliescu C. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience. JACC CardioOncol 3(3):452-456, 2021. e-Pub 2021. PMID: 34604808.
5. Pushparaji B, Donisan T, Balanescu DV, Palaskas N, Kim P, Lopez-Mattei J, Cilingiroglu M, Hassan SA, Boudoulas KD, Marmagkiolis K, Hajjar LA, Iliescu CA. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep 23(11):133, 2021. e-Pub 2021. PMID: 34570291.
6. Zarifa A, Kim JW, Lopez-Mattei J, Palaskas N, Iliescu C, Kim PY. Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management. Korean Circ J 51(7):579-597, 2021. PMID: 34227272.
7. Zhang L, Reynolds KL, Lyon AR, Palaskas N, Neilan TG. The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer. JACC CardioOncol 3(1):35-47, 2021. e-Pub 2021. PMID: 33842895.
8. Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 22(12):171, 2020. e-Pub 2020. PMID: 33040241.
9. Simbaqueba CC, Aponte MP, Kim P, Deswal A, Palaskas NL, Iliescu C, Jahangir E, Yang EH, Steiner RE, Lopez-Mattei J.. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. Journal of Immunotherapy and Precision Oncology 3(3):113-120, 2020.
10. Palaskas NL, Lopez-Mattei J. The Role of Echocardiography in the Cancer Patient. Curr Cardiol Rep 22(10):1-11, 2020. e-Pub 2020. PMID: 32770406.
11. Raghunathan D, Palaskas NL, Yusuf SW, Eagle KA. Rise and fall of preoperative coronary revascularization. Expert Rev Cardiovasc Ther 18(5):249-259, 2020. e-Pub 2020. PMID: 32299259.
12. Pushparaji B, Marmagkiolis K, Miller C, Aziz M, Balanescu D, Donisan T, Palaskas N, Kim P, Lopez-Matei J, Cilingiroglu M, Hassan S, Iliescu C. State-of-the-art Review: Interventional Onco-Cardiology. Current Treatment Options in Cardiovascular Medicine 22(11), 2020.
13. Palaskas N, Lopez-Mattei JC, Durand JB, Iliescu C, Deswal. Immune Checkpoint Inhibitor Myocarditis: Pathophysiology, Diagnosis, and Treatment. American Heart A 9(2):1-12, 2020. PMID: 31960755.
14. Parwani P, Co M, Ramesh T, Akhter N, Iliescu C, Palaskas N, Kim P, Gladish G,. Differentiation of Cardiac Masses by Cardiac Magnetic Resonance Imaging. Current Cardiovascular Imaging Reports 13(1), 2020.
15. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim PY. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. Adv Exp Med Biol 1244:277-285, 2020. PMID: 32301022.
16. Koutroumpakis E, Palaskas NL, Lin SH, Abe JI, Liao Z, Banchs J, Deswal A, Yusuf SW. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy 65(3-4):65-76, 2020. PMID: 33049738.
17. Boone DL, Thanikachalam S, Cervoni-Curet F, Balanescu DV, Donisan T, Iliescu G, Palaskas N, lopez-Mattei J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Coronary intervention in cancer patients: the need for personalized cardiac care. Romanian Journal of Cardiology 20(3):389-398, 2020.
18. Agha A, Zarifa A, Kim P, Iliescu C, Gladish G, Hassan S, Palaskas N, Durand JB, Lu Y, Lopez J. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. METHODIST DEBAKEY CARDIOVASC J:258-266, 2019. PMID: 31988686.
19. Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Karimzad K, Kim P, Charitakis K, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin 37(4):469-486, 2019. PMID: 31587788.
20. Hassan SA, Palaskas NL, Agha AM, Iliescu C, Lopez-Mattei J, Chen C, Zheng H, Yusuf SW. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep 21(11):140, 2019. e-Pub 2019. PMID: 31745664.
21. Zarifa A, Albittar A, Kim PY, Hassan S, Palaskas N, Iliescu C, Durand JB, Lopez-Mattei J. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy. Curr Opin Cardiol 34(4):441-450, 2019. PMID: 31082852.
22. Balanescu SM, Balanescu DV, Donisan T, Yang EH, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Cilingiroglu M, Marmagkiolis K, Kar B, Iliescu C. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?. Curr Cardiol Rep 21(8):83, 2019. e-Pub 2019. PMID: 31286273.
23. Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, Palaskas N, Iliescu C, Kim P, Yusuf SW, Hassan SA. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography 36(2):229-236, 2019. e-Pub 2018. PMID: 30569522.
24. Donisan T, Balanescu D, Iliescu G, Lopez J, Palaskas N, Kim P, Durand JB, Balanescu S, Marmagkiolis K, Iliescu C. Acute drops in ejection fraction in contemporary cardio-oncology: old diagnosis, new offenders. Romanian Journal of Cardiology 29(2):246-250, 2019.
25. Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, Kim PY, Palaskas NL, Yusuf S, Gladish G, Hassan S. Multimodality imaging in carcinoid heart disease. Open Heart 6(1):e001060, 2019. e-Pub 2019. PMID: 31245014.
26. Palaskas N, Patel A, Yusuf SW. Radiation and cardiovascular disease. Ann Transl Med 7(Suppl 8):S371, 2019. PMID: 32016089.
27. Zarifa A, Salih M, Lopez-Mattei J, Lee HJ, Iliescu C, Hassan S, Palaskas N, Durand JB, Mouhayar E, Kim J, Kim P. Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but. Journal of Immunotherapy and Precision Oncology:68-77, 2018.
28. Moudgil R, Hassan S, Palaskas N, Lopez-Mattei J, Banchs J, Yusuf SW. Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction. Echocardiography 35(6):860-868, 2018. e-Pub 2018. PMID: 29749652.
29. Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, Kim P, Durand JB, Lopez-Mattei JC. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med 20(4):29, 2018. e-Pub 2018. PMID: 29556752.
30. Hassan SA, Palaskas N, Kim P, Iliescu C, Lopez-Mattei J, Mouhayar E, Mougdil R, Thompson K, Banchs J, Yusuf SW. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep 20(2):10, 2018. e-Pub 2018. PMID: 29423705.
31. Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Frontiers Cardiovasc Med 5(48):48, 2018. e-Pub 2018. PMID: 29868614.
32. Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, Palaskas NL, Gladish G, Kim PY, Lopez-Mattei J. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 5(2):e000881, 2018. e-Pub 2018. PMID: 30305910.
33. Shah T, Palaskas N, Ahmed A. An Update on Gender Disparities in Coronary Heart Disease Care. Curr Atheroscler Rep 18(5):28, 2016. PMID: 27029220.

Other Articles

1. Balanescu DV, Donisan T, Palaskas NL, Iliescu C Emerging Concerns in Cardio-Oncology: Immune Checkpoint Inhibitor Cardiotoxicity, 2019.

Editorials

1. Lopez-Mattei JC, Palaskas N, Iliescu C. Skip Soft Definitions and Focus on Hard Endpoints. JACC:CardioOncology 1(2):218-220, 2019.

Book Chapters

1. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim P.. Immune checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. In: Immunotherapy 4th Edition. 2021, 2021.
2. Raymundo A Quintana, Nicolas Palaskas, Jose Banchs. Hemodynamic Evaluation and Echocardiography in the Oncologic Intensive Care Uni. In: Oncologic Critical Care. Springer, 1-21, 2019.
3. Palaskas N, Ewer MS.. Cardiac Monitoring During Clinical Trials. In: Cancer and the Heart 3rd Edition, 2019.
4. Palaskas N, Levine G.. Echocardiography. In: Cardiology Secrets. 5th Edition. Glenn Levine. Elselvier: Philadelphia, PA, 54-64, 2017.
5. Shah T, Palaskas N, Bozkurt B.. "Heart Failure, Introduction" Pathophysiology and Pharmacotherapy of Cardiovascular Disease. In: Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Gowraganahalli Jagadeesh. Springer International Publishing: Switzerland, 3-20, 2015.